Why IMA? ImageneBio, Inc. Analysis, Price & AI Insights | Whystock
IMA
$5.66-0.35 (-5.82%)
Market ClosedLast close May 1
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases.